share_log

復宏漢霖:自願公告 - HLX78(拉索昔芬片)聯合阿貝西利對比氟維司群聯合阿貝西利用於局部晚期或轉移性乳腺癌的國際多中心3期臨床研究完成中國境內首例患者給藥

HENLIUS: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT IN MAINLAND CHINA HAS BEEN DOSED IN AN INTERNATIONAL MULTI-CENTER PHASE 3 CLINICAL STUDY OF THE COMBINATION OF HLX78 (LASOFOXIFENE) AND ABEMACICLIB COMPARED TO THE COMBINATION OF FULVESTRANT AND ABEMACICLIB FOR THE TR

HKEX ·  Dec 24 17:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more